Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss the changing treatment landscape of patients with advanced or metastatic HER2-positive breast cancer.
EP. 1: Current Prognosis for Advanced or Metastatic HER2+ Breast Cancer
Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss the prognosis for patients with advanced or metastatic HER2-positive breast cancer.
EP. 2: Optimal Management Strategies in Advanced HER2+ Breast Cancer
Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss the various management strategies for treatment of patients with advanced or metastatic HER2-positive breast cancer.
EP. 3: Treatment Decisions in Advanced HER2+ Breast Cancer With CNS Metastases
Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss how to decide on treatment for patients with advanced or metastatic HER2-positive breast cancer who have central nervous system metastases.
EP. 4: Frequent AEs and Management Approaches for Advanced HER2+ Breast Cancer
Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss commonly reported adverse effects from HER2-positive breast cancer treatment and appropriate management strategies for them.
EP. 5: Investigational Agents, Clinical Trials for Advanced HER2+ Breast Cancer
Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss novel agents in the pipeline for patients with advanced HER2-positive breast cancer.
Experts Highlight Noteworthy Research From the 2024 ESMO Congress
MR-Linac Radiotherapy Limits Target Volume, Brain Tissue Exposure in High-Grade Glioma
PFS Data for 177Lu-Dotatate Surpass Clinical Benchmarks in Refractory Meningioma
Nivolumab Plus Radiotherapy Reduces Rates of Biochemical Recurrence in Gleason Grade 5 Prostate Cancer